Law360, New York (January 17, 2007, 12:00 AM ET) -- The chairman of the Senate Judiciary Committee said Wednesday he would introduce legislation to ban so-called reverse payments, saying deals between branded and generic drug makers delay cheaper drugs and cost consumers billions of dollars.
Sen. Patrick Leahy, a Democrat from Vermont, dubbed the bill the Preserve Access to Affordable Generics Act and revealed it during a meeting of the Senate Judiciary Committee on Capitol Hill.
According to Sen. Leahy and the bill's cosponsors, the act would explicitly prohibit brand-name drug makers from using payoff agreements...
Senate Bill Targets Reverse Payments
To view the full article, take a free trial now.
